Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Diagnostic error as a result of drug-laboratory test interactions.

van Balveren JA, Verboeket-van de Venne WPHG, Erdem-Eraslan L, de Graaf AJ, Loot AE, Musson REA, Oosterhuis WP, Schuijt MP, van der Sijs H, Verheul RJ, de Wolf HK, Kusters R, Hoedemakers RMJ; Dutch Society for Clinical Chemistry and Laboratory Medicine, task group ‘SMILE’: Signalling Medication Interactions and Laboratory test Expert system.

Diagnosis (Berl). 2019 Mar 26;6(1):69-71. doi: 10.1515/dx-2018-0098.

PMID:
30753158
2.

Adding clinical utility to the laboratory reports: automation of interpretative comments.

Oosterhuis W.

Clin Chem Lab Med. 2019 Feb 25;57(3):365-370. doi: 10.1515/cclm-2018-0623.

PMID:
30367781
3.

Impact of interactions between drugs and laboratory test results on diagnostic test interpretation - a systematic review.

van Balveren JA, Verboeket-van de Venne WPHG, Erdem-Eraslan L, de Graaf AJ, Loot AE, Musson REA, Oosterhuis WP, Schuijt MP, van der Sijs H, Verheul RJ, de Wolf HK, Kusters R, Hoedemakers RMJ; Dutch Society for Clinical Chemistry and Laboratory Medicine, task group ‘SMILE’: Signaling Medication Interactions and Laboratory test Expert system.

Clin Chem Lab Med. 2018 Nov 27;56(12):2004-2009. doi: 10.1515/cclm-2018-0900. Review.

PMID:
30332390
4.

Sigma metrics in laboratory medicine revisited: We are on the right road with the wrong map.

Oosterhuis WP, Coskun A.

Biochem Med (Zagreb). 2018 Jun 15;28(2):020503. doi: 10.11613/BM.2018.020503. Review.

5.

Performance specifications and six sigma theory: Clinical chemistry and industry compared.

Oosterhuis WP, Severens MJ.

Clin Biochem. 2018 Jul;57:12-17. doi: 10.1016/j.clinbiochem.2018.04.002. Epub 2018 Apr 11.

PMID:
29654729
6.

Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy ('4P medicine').

Orth M, Averina M, Chatzipanagiotou S, Faure G, Haushofer A, Kusec V, Machado A, Misbah SA, Oosterhuis W, Pulkki K, Twomey PJ, Wieland E.

J Clin Pathol. 2019 Mar;72(3):191-197. doi: 10.1136/jclinpath-2017-204734. Epub 2017 Dec 22.

7.

Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference.

Panteghini M, Ceriotti F, Jones G, Oosterhuis W, Plebani M, Sandberg S; Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).

Clin Chem Lab Med. 2017 Oct 26;55(12):1849-1856. doi: 10.1515/cclm-2017-0772.

8.

The use of error and uncertainty methods in the medical laboratory.

Oosterhuis WP, Bayat H, Armbruster D, Coskun A, Freeman KP, Kallner A, Koch D, Mackenzie F, Migliarino G, Orth M, Sandberg S, Sylte MS, Westgard S, Theodorsson E.

Clin Chem Lab Med. 2018 Jan 26;56(2):209-219. doi: 10.1515/cclm-2017-0341.

9.

A survey of patients' views from eight European countries of interpretive support from Specialists in Laboratory Medicine.

Watson ID, Oosterhuis WP, Jorgensen PE, Dikmen ZG, Siodmiak J, Jovicic S, Aakre KM, Palicka V, Kutt M; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Patient Focused Laboratory Medicine.

Clin Chem Lab Med. 2017 Aug 28;55(10):1496-1500. doi: 10.1515/cclm-2017-0080.

10.

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

Schmidt MK, van den Broek AJ, Tollenaar RA, Smit VT, Westenend PJ, Brinkhuis M, Oosterhuis WJ, Wesseling J, Janssen-Heijnen ML, Jobsen JJ, Jager A, Voogd AC, van Leeuwen FE, van 't Veer LJ.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw329.

PMID:
28376189
11.

Could accreditation bodies facilitate the implementation of medical guidelines in laboratories?

Aakre KM, Oosterhuis WP, Misra S, Langlois MR, Joseph W, Twomey PJ, Barth JH.

Clin Chem Lab Med. 2017 May 1;55(6):806-808. doi: 10.1515/cclm-2016-0577.

12.

How Useful are Laboratory Practice Guidelines?

Misra S, Moberg-Aakre K, Langlois M, Watine J, Twomey PJ, Oosterhuis WP, Barth JH.

EJIFCC. 2015 Aug 24;26(3):190-6. eCollection 2015 Aug.

13.

The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey.

Plebani M, O'Kane M, Vermeersch P, Cadamuro J, Oosterhuis W, Sciacovelli L; EFLM Task Force on “Performance specifications for the extra-analytical phases” (TFG-PSEP).

Clin Chem Lab Med. 2016 Nov 1;54(11):e315-e317. doi: 10.1515/cclm-2016-0770. No abstract available.

14.

Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.

Papathomas TG, Duregon E, Korpershoek E, Restuccia DF, van Marion R, Cappellesso R, Sturm N, Rossi G, Coli A, Zucchini N, Stoop H, Oosterhuis W, Ventura L, Volante M, Fassina A, Dinjens WN, Papotti M, de Krijger RR.

Hum Pathol. 2016 Dec;58:113-122. doi: 10.1016/j.humpath.2016.08.006. Epub 2016 Aug 31.

PMID:
27589897
15.

Sigma metric or defects per million opportunities (DPMO): the performance of clinical laboratories should be evaluated by the Sigma metrics at decimal level with DPMOs.

Coskun A, Oosterhuis WP, Serteser M, Unsal I.

Clin Chem Lab Med. 2016 Aug 1;54(8):e217-9. doi: 10.1515/cclm-2015-1219. No abstract available.

PMID:
26760310
16.

Why are clinical practice guidelines not followed?

Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, Twomey PJ, Oosterhuis WP.

Clin Chem Lab Med. 2016 Jul 1;54(7):1133-9. doi: 10.1515/cclm-2015-0871. Review.

17.

Total error vs. measurement uncertainty: revolution or evolution?

Oosterhuis WP, Theodorsson E.

Clin Chem Lab Med. 2016 Feb;54(2):235-9. doi: 10.1515/cclm-2015-0997.

18.

European views on patients directly obtaining their laboratory test results.

Watson ID, Siodmiak J, Oosterhuis WP, Corberand J, Jorgensen PE, Dikmen ZG, Jovicic S, Theodorsson E; EFLM Working Group on Patient Focused Laboratory Medicine.

Clin Chem Lab Med. 2015 Nov;53(12):1961-6. doi: 10.1515/cclm-2015-0056.

19.

Proposal for the modification of the conventional model for establishing performance specifications.

Oosterhuis WP, Sandberg S.

Clin Chem Lab Med. 2015 May;53(6):925-37. doi: 10.1515/cclm-2014-1146.

20.

Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine.

Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, Petersen PH, Schimmel H, Sikaris K, Panteghini M.

Clin Chem Lab Med. 2015 May;53(6):833-5. doi: 10.1515/cclm-2015-0067. No abstract available.

21.

Virilizing adrenal oncocytoma in a 9-year-old girl: rare neoplasm with an intriguing postoperative course.

Yordanova G, Iotova V, Kalchev K, Ivanov K, Balev B, Kolev N, Tonev A, Oosterhuis W.

J Pediatr Endocrinol Metab. 2015 May;28(5-6):685-90. doi: 10.1515/jpem-2014-0308.

PMID:
25514324
22.

The quality of laboratory aspects of troponin testing in clinical practice guidelines and consensus documents needs to be improved.

Aakre KM, Langlois MR, Barth JH, Misra S, Watine J, Oosterhuis WP.

Clin Chim Acta. 2014 Nov 1;437:58-61. doi: 10.1016/j.cca.2014.07.006. Epub 2014 Jul 15.

PMID:
25036763
23.

Laboratory medicine in the European Union.

Oosterhuis WP, Zerah S.

Clin Chem Lab Med. 2015 Jan;53(1):5-14. doi: 10.1515/cclm-2014-0407. Review.

24.

A multicenter evaluation of dysthyroxinemia in a defined patient cohort.

Vogt MH, Bons JA, Janssen MJ, Naus A, Oosterhuis W, Ten Kate J, Menheere PP.

Clin Chem Lab Med. 2014 Aug;52(8):1153-8. doi: 10.1515/cclm-2014-0063.

PMID:
24717338
25.

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group.

Langlois MR, Descamps OS, van der Laarse A, Weykamp C, Baum H, Pulkki K, von Eckardstein A, De Bacquer D, Borén J, Wiklund O, Laitinen P, Oosterhuis WP, Cobbaert C; EAS-EFLM Collaborative Project.

Atherosclerosis. 2014 Mar;233(1):83-90. doi: 10.1016/j.atherosclerosis.2013.12.016. Epub 2014 Jan 4.

PMID:
24529127
26.

Evaluation of ICSH schistocyte measurement guidelines in France.

Lesesve JF, El Adssi H, Watine J, Oosterhuis W, Régnier F.

Int J Lab Hematol. 2013 Dec;35(6):601-7. doi: 10.1111/ijlh.12092. Epub 2013 Apr 22.

PMID:
23601189
27.

The role of the physician in laboratory medicine: a European perspective.

Misbah SA, Kokkinou V, Jeffery K, Oosterhuis W, Shine B, Schuh A, Theodoridis T.

J Clin Pathol. 2013 May;66(5):432-7. doi: 10.1136/jclinpath-2012-201042. Epub 2012 Dec 8.

PMID:
23223566
28.

Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation.

Aakre KM, Langlois MR, Watine J, Barth JH, Baum H, Collinson P, Laitinen P, Oosterhuis WP.

Clin Chem Lab Med. 2013 Jun;51(6):1217-26. Review.

PMID:
23037517
29.

Accuracy of first and second generation testosterone assays and improvement through sample extraction.

Groenestege WM, Bui HN, ten Kate J, Menheere PP, Oosterhuis WP, Vader HL, Heijboer AC, Janssen MJ.

Clin Chem. 2012 Jul;58(7):1154-6. doi: 10.1373/clinchem.2011.181735. Epub 2012 Apr 26. No abstract available.

30.

Self-monitoring of blood glucose in patients with diabetes who do not use insulin--are guidelines evidence-based?

Aakre KM, Watine J, Bunting PS, Sandberg S, Oosterhuis WP.

Diabet Med. 2012 Oct;29(10):1226-36. doi: 10.1111/j.1464-5491.2012.03659.x. Review.

PMID:
22435892
31.

How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests?

Aakre KM, Oosterhuis WP, Sandberg S.

Scand J Clin Lab Invest. 2012 Apr;72(2):143-51. doi: 10.3109/00365513.2011.646298. Epub 2012 Jan 3.

PMID:
22214324
32.

Histological assessment of PAXgene tissue fixation and stabilization reagents.

Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, Viertler C, Groelz D, Becker KF, Zatloukal K, Langer R, Slotta-Huspenina J, Bodo K, de Jong B, Oelmuller U, Riegman P.

PLoS One. 2011;6(11):e27704. doi: 10.1371/journal.pone.0027704. Epub 2011 Nov 16.

33.

Gross overestimation of total allowable error based on biological variation.

Oosterhuis WP.

Clin Chem. 2011 Sep;57(9):1334-6. doi: 10.1373/clinchem.2011.165308. Epub 2011 Jun 20. No abstract available.

34.

Anterior lumbar discectomy and disc replacement.

Zeilstra D, Oosterhuis W.

Eur Spine J. 2011 Jun;20(6):991-2. doi: 10.1007/s00586-011-1805-7. No abstract available.

PMID:
21541670
35.

Diagnosis of testicular carcinoma in situ '(intratubular and microinvasive)' seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections.

Stoop H, Kirkels W, Dohle GR, Gillis AJ, den Bakker MA, Biermann K, Oosterhuis W, Looijenga LH.

Histopathology. 2011 Feb;58(3):440-6. doi: 10.1111/j.1365-2559.2011.03767.x. Epub 2011 Feb 16.

PMID:
21323965
36.

Reflective testing: adding value to laboratory testing.

Verboeket-van de Venne WP, Aakre KM, Watine J, Oosterhuis WP.

Clin Chem Lab Med. 2012 Apr 28;50(7):1249-52. doi: 10.1515/cclm-2011-0611.

PMID:
22850057
37.

Drastic effects of cryoglobulin on blood cell counts, erythrocyte morphology and M-protein analysis.

Keuren JF, Raijmakers MT, Oosterhuis WP, Leers MP.

Scand J Clin Lab Invest. 2010 Oct;70(6):462-4. doi: 10.3109/00365513.2010.507874. No abstract available.

PMID:
20687776
38.

Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: a European survey in primary care.

Aakre KM, Thue G, Subramaniam-Haavik S, Cooper J, Bukve T, Morris HA, Müller M, Lovrencic MV, Plum I, Kallion K, Aab A, Kutt M, Gillery P, Schneider N, Horvath AR, Onody R, Oosterhuis W, Ricos C, Perich C, Nordin G, Sandberg S.

Diabetes Res Clin Pract. 2010 Aug;89(2):103-9. doi: 10.1016/j.diabres.2010.03.023. Epub 2010 Apr 21.

PMID:
20409604
39.

The value of the Thomas-plot in the diagnostic work up of anemic patients referred by general practitioners.

Leers MP, Keuren JF, Oosterhuis WP.

Int J Lab Hematol. 2010 Dec;32(6 Pt 2):572-81. doi: 10.1111/j.1751-553X.2010.01221.x.

PMID:
20175793
40.

alpha-thalassaemia masked by beta gene defects and a new polyadenylation site mutation on the alpha2-globin gene.

Harteveld CL, Oosterhuis WP, Schoenmakers CH, Ananta H, Kos S, Bakker Verweij M, van Delft P, Arkesteijn SG, Phylipsen M, Giordano PC.

Eur J Haematol. 2010 Apr;84(4):354-8. doi: 10.1111/j.1600-0609.2009.01380.x. Epub 2009 Nov 12.

PMID:
19912309
41.

[Laboratory input. General practitioners positive about reflective testing].

Oosterhuis WP, Keuren JF, Verboeket-van de Venne WP, Soomers FL, Stoffers HE, Kleinveld HA.

Ned Tijdschr Geneeskd. 2009;153:A486. Dutch.

PMID:
19900340
42.

Reflective testing in the Netherlands: usefulness to improve the diagnostic and therapeutic process in general practice.

Verboeket-van de Venne WP, Oosterhuis WP, Keuren JF, Kleinveld HA.

Ann Clin Biochem. 2009 Jul;46(Pt 4):346-7. doi: 10.1258/acb.2009.009039. Epub 2009 May 19. No abstract available.

PMID:
19454541
43.

Detection of a monoclonal gammopathy by serum index measurement.

Oosterhuis W, Kleinveld H, Mücke M.

Clin Chem Lab Med. 2009;47(5):614-5. doi: 10.1515/CCLM.2009.128. No abstract available.

PMID:
19278372
44.

Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development?

Nagy E, Watine J, Bunting PS, Onody R, Oosterhuis WP, Rogic D, Sandberg S, Boda K, Horvath AR; IFCC Task Force on the Global Campaign for Diabetes Mellitus.

Clin Chem. 2008 Nov;54(11):1872-82. doi: 10.1373/clinchem.2008.109082. Epub 2008 Sep 4.

45.

Postanalytical external quality assessment of urine albumin in primary health care: an international survey.

Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Müller M, Lovrencic MV, Plum I, Kallion K, Aab A, Kutt M, Gillery P, Schneider N, Horvath AR, Onody R, Oosterhuis W, Ricos C, Perich C, Nordin G, Sandberg S.

Clin Chem. 2008 Oct;54(10):1630-6. doi: 10.1373/clinchem.2007.100917. Epub 2008 Aug 14.

46.

Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up.

van Mieghem C, Ramcharitar S, Barlis P, Oosterhuis W, Kik C, de Feyter P, Serruys PW.

EuroIntervention. 2008 Mar;3(5):627-34.

PMID:
19608492
47.

Heterogeneous distribution of ITGCNU in an adult testis: consequences for biopsy-based diagnosis.

van Casteren NJ, Boellaard WP, Dohle GR, Weber RF, Kuizinga MC, Stoop H, Oosterhuis WJ, Looijenga LH.

Int J Surg Pathol. 2008 Jan;16(1):21-4. doi: 10.1177/1066896907306125.

PMID:
18203779
48.
49.

One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries.

Coebergh JW, van Veen EB, Vandenbroucke JP, van Diest P, Oosterhuis W.

BMJ. 2006 Mar 18;332(7542):665. No abstract available.

50.

Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

Watine J, Friedberg B, Nagy E, Onody R, Oosterhuis W, Bunting PS, Charet JC, Horvath AR.

Clin Chem. 2006 Jan;52(1):65-72. Review.

Supplemental Content

Loading ...
Support Center